| 1. | Amlexanox-loaded nanoliposomes showing enhanced anti-inflammatory activity in cultured macrophages: A potential formulation for treatment of oral aphthous stomatitis | 315 | 62 |
| 2. | Sustained Delivery of Salbutamol and Beclometasone From Spray-dried Double Emulsions | 220 | |
| 3. | Comparison of the scope of practice of physician associates with that of healthcare professions with prescribing responsibility from point of registration | 197 | 30 |
| 4. | Prodrug to Probe Solution HFA pMDI Formulation and Pulmonary Esterase Activity | 175 | |
| 5. | An Investigation of the Solubility of Various Compounds in the Hydrofluoroalkane Propellants and Possible Model Liquid Propellants | 171 | |
| 6. | Fluorescence Lifetime Imaging of Optically Levitated Aerosol: a Technique to Quantitatively Map the Viscosity of Suspended Aerosol Particles | 168 | 57 |
| 7. | The Use of Sodium Carboxymethylcellulose in the Preparation of Spray-dried Proteins for Pulmonary Drug Delivery | 158 | |
| 8. | Preparation of Dry Powder Dispersions for Non-viral Gene Delivery by Freeze-drying and Spray-drying | 149 | |
| 9. | Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene Therapy | 148 | |
| 10. | The Use of Absorption Enhancers to Enhance the Despersibility of Spray-dried Powders for Pulmonary Gene Therapy | 145 | |
| 11. | Sustained Delivery by Leucine-modified Chitosan Spray-dried Respirable Powders | 144 | |
| 12. | Carbomer-modified Spray-dried Respirable Powders for Pulmonary Delivery of Salbutamol Sulphate | 144 | |
| 13. | The Use of Amino Acids to Enhance the Aerosolisation of Spray-dried Powders for Pulmonary Gene Therapy | 142 | |
| 14. | Novel pMDI Formulations for Pulmonary Delivery of Proteins | 138 | |
| 15. | Rapid Interrogation of the Physical and Chemical Characteristics of Salbutamol Sulphate Aerosol from a Pressurised Metered-dose Inhaler (pMDI) | 138 | |
| 16. | Amino Acid-modified Spray-dried Powders with Enhanced Aerosolisation Properties for Pulmonary Drug Delivery | 137 | |
| 17. | The Influence of Formulation Components on the Aerosolisation Properties of Spray-dried Powders | 135 | |
| 18. | Measurement of the Raman Spectra and Hygroscopicity of Four Pharmaceutical Aerosols as They Travel from Pressurised Metered Dose Inhalers (pMDI) to a Model Lung | 132 | 93 |
| 19. | Further Evidence of Extensive Pulmonary First-pass Ester Hydrolysis After Airways Administration in Rats | 128 | |
| 20. | Influence of Excipients on Spray-dried Powders for Inhalation | 123 | |
| 21. | Modified Release of Beclometasone Dipropionate from Chitosan-based Spray-dried Respirable Powders | 121 | |
| 22. | Chitosan-based Spray-dried Respirable Powders for Sustained Delivery of Terbutaline Sulfate | 119 | |
| 23. | Spray-dried Powders for Pulmonary Drug Delivery | 108 | |